Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients

BACKGROUND: In synovial sarcomas alterations in the cyclin D1-CDK4/6-Rb axis have been described. Also, β-catenin, a cyclin D1 regulator, is often overexpressed. Additionally, studies have shown that the t(X;18) translocation influences tumor behavior partly through cyclin D1 activation. We investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Vlenterie, Myrella, Hillebrandt-Roeffen, Melissa H. S., Schaars, Esther W. M., Flucke, Uta E., Fleuren, Emmy D. G., Navis, Anna C., Leenders, William P. J., Versleijen-Jonkers, Yvonne M. H., van der Graaf, Winette T. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Bone and Soft Tissue Sarcomas
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972869/
https://www.ncbi.nlm.nih.gov/pubmed/27334220
http://dx.doi.org/10.1245/s10434-016-5341-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972869/
https://www.ncbi.nlm.nih.gov/pubmed/27334220
http://dx.doi.org/10.1245/s10434-016-5341-x

Ejemplares similares